As Brazil authorizes the use of SinoVac's CoronaVac for a national vaccination campaign, questions remain about its efficacy. So what is going on, and does it have anything to do with bias against China? And as issues arise with other vaccine candidates, how will public concerns be addressed?

Guest:
Helen Yang 
Senior Director of International Business Development
Sinovac Biotech